NDRG2 and colorectal carcinoma: Several studies have shown NDRG2 promoter CpG island methylation and down-regulation in liver [13], gastric [10], colorectal cancers (CRC) [23, 24], glioblastomas [8, 9] and anaplastic meningioma [25].